Simris Group AB (PUBL) (STO:SIMRIS.B)
0.0874
-0.0074 (-7.81%)
Nov 20, 2026, 5:25 PM CET
Simris Group AB (PUBL) Market Cap
Simris Group AB (PUBL) has a market cap or net worth of 137.49 million as of November 20, 2026. It is the 39,166th most valuable company in the world and the 557th biggest in Sweden. Its market cap has increased by 119.93% in one year.
Market Cap
137.49M
Enterprise Value
127.06M
Revenue
1.14M
Global Rank
Country Rank
#557 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2016, Simris Group AB (PUBL)'s market cap has increased from 122.27M to 137.49M, an increase of 12.45%. That is a compound annual growth rate of 1.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 137.49M | 413.86% |
| Dec 30, 2025 | 26.76M | 0.88% |
| Dec 30, 2024 | 26.52M | -66.13% |
| Dec 29, 2023 | 78.32M | 72.71% |
| Dec 30, 2022 | 45.35M | -21.98% |
| Dec 30, 2021 | 58.12M | 3.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 213.27M |
| Initiator Pharma | 171.13M |
| Elicera Therapeutics AB | 164.51M |
| Abera Bioscience AB | 140.62M |
| Diamyd Medical AB | 138.25M |
| BioInvent International AB | 137.53M |
| Xintela AB | 121.44M |
| IRLAB Therapeutics AB | 108.41M |